{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T14:51:13Z","timestamp":1785682273543,"version":"3.56.0"},"reference-count":88,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Context.<\/jats:italic>\n                    \u2014Medullary carcinoma (MC) is a special type of breast cancer that has a better prognosis than atypical medullary carcinoma (AMC) and high-grade invasive ductal carcinoma (HGIDC) with prominent lymphocytic infiltrates. What accounts for the different clinical courses of these carcinomas, despite their similar histology, is unknown. To address this issue, we performed a comparative study of amplification and overexpression of HER-2\/\n                    <jats:italic>neu<\/jats:italic>\n                    and expression of several other important biochemical markers (p53, MIB1, and estrogen receptor [ER]\/progesterone receptor [PR]) in these 3 cancer groups.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Objective.<\/jats:italic>\n                    \u2014To evaluate HER-2\/\n                    <jats:italic>neu,<\/jats:italic>\n                    p53, MIB1, and ER\/PR as markers in the differential diagnosis of MC, AMC, and HGIDC.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Design.<\/jats:italic>\n                    \u2014Nine cases of MC, 13 cases of AMC, and 16 cases of HGIDC with prominent lymphocytic infiltrates were identified according to strict histologic criteria. All tests were performed on formalin-fixed, paraffin-embedded archival tissues.\n                    <jats:italic>HER-2\/neu<\/jats:italic>\n                    gene amplification was examined by fluorescence in situ hybridization using PathVysion HER-2 DNA probes. Expression of HER-2\/\n                    <jats:italic>neu,<\/jats:italic>\n                    p53, MIB1, and ER\/PR was detected by immunohistochemistry. \u03c7\n                    <jats:sup>2<\/jats:sup>\n                    and Student\n                    <jats:italic>t<\/jats:italic>\n                    tests were applied for statistical analyses.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Results.<\/jats:italic>\n                    \u2014None of 9 cases of MC examined had either amplification or overexpression of HER-2\/\n                    <jats:italic>neu<\/jats:italic>\n                    (0%). In contrast,\n                    <jats:italic>HER-2\/neu<\/jats:italic>\n                    amplification was observed in AMC (46%,\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .025) and HGIDC (56%,\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .005). All 3 categories of tumors had similar percentages of expression of p53 (78% of MC, 77% of AMC, and 69% of HGIDC) and MIB1 (89% of MC, 92% of AMC, and 94% of HGIDC). Immunostaining for ER\/PR was rarely positive in either MC or AMC, and there were no significant differences of expression of ER\/PR between these 2 lesions (\n                    <jats:italic>P<\/jats:italic>\n                    &gt; .05). However, the expression rate of ER\/PR (31%\/44%) in HGIDC is higher than in both MC (\n                    <jats:italic>P<\/jats:italic>\n                    = .05) and AMC (\n                    <jats:italic>P<\/jats:italic>\n                    = .01).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusions.<\/jats:italic>\n                    \u2014Medullary carcinoma of breast is distinct from AMC and HGIDC with prominent lymphocytic infiltrates in amplification and overexpression of HER-2\/\n                    <jats:italic>neu.<\/jats:italic>\n                    This difference may account for its different clinical and biological behavior, and may potentially aid in diagnosis and management of these groups of patients.\n                  <\/jats:p>","DOI":"10.5858\/2003-127-1458-daaoon","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T12:33:51Z","timestamp":1612787631000},"page":"1458-1464","source":"Crossref","is-referenced-by-count":17,"title":["Differential Amplification and Overexpression of HER-2\/neu, p53, MIB1, and Estrogen Receptor\/Progesterone Receptor Among Medullary Carcinoma, Atypical Medullary Carcinoma, and High-Grade Invasive Ductal Carcinoma of Breast"],"prefix":"10.5858","volume":"127","author":[{"given":"Ruliang","family":"Xu","sequence":"first","affiliation":[{"name":"From the Department of Pathology, Mount Sinai School of Medicine of New York University, New York, NY (Dr Xu); Department of Anatomic Pathology, Quest Diagnostics, Teterboro, NJ (Dr Feiner); and Department of Pathology, New York University School of Medicine, New York, NY (Drs Feiner, Li, Yee, Inghirami, Delgado, and Perle)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Feiner","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Mount Sinai School of Medicine of New York University, New York, NY (Dr Xu); Department of Anatomic Pathology, Quest Diagnostics, Teterboro, NJ (Dr Feiner); and Department of Pathology, New York University School of Medicine, New York, NY (Drs Feiner, Li, Yee, Inghirami, Delgado, and Perle)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Mount Sinai School of Medicine of New York University, New York, NY (Dr Xu); Department of Anatomic Pathology, Quest Diagnostics, Teterboro, NJ (Dr Feiner); and Department of Pathology, New York University School of Medicine, New York, NY (Drs Feiner, Li, Yee, Inghirami, Delgado, and Perle)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Yee","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Mount Sinai School of Medicine of New York University, New York, NY (Dr Xu); Department of Anatomic Pathology, Quest Diagnostics, Teterboro, NJ (Dr Feiner); and Department of Pathology, New York University School of Medicine, New York, NY (Drs Feiner, Li, Yee, Inghirami, Delgado, and Perle)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Inghirami","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Mount Sinai School of Medicine of New York University, New York, NY (Dr Xu); Department of Anatomic Pathology, Quest Diagnostics, Teterboro, NJ (Dr Feiner); and Department of Pathology, New York University School of Medicine, New York, NY (Drs Feiner, Li, Yee, Inghirami, Delgado, and Perle)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Delgado","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Mount Sinai School of Medicine of New York University, New York, NY (Dr Xu); Department of Anatomic Pathology, Quest Diagnostics, Teterboro, NJ (Dr Feiner); and Department of Pathology, New York University School of Medicine, New York, NY (Drs Feiner, Li, Yee, Inghirami, Delgado, and Perle)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Perle","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Mount Sinai School of Medicine of New York University, New York, NY (Dr Xu); Department of Anatomic Pathology, Quest Diagnostics, Teterboro, NJ (Dr Feiner); and Department of Pathology, New York University School of Medicine, New York, NY (Drs Feiner, Li, Yee, Inghirami, Delgado, and Perle)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"key":"i1543-2165-127-11-1458-b1","series-title":"Cancer","first-page":"1365","article-title":"Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up.","volume":"40","author":"Ridolfi, R. L.","year":"1977","unstructured":"Ridolfi, R. L., P. P.Rosen, A.Port, D.Kinne, and V.Mike. Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up.Cancer1977. 40:1365\u20131385."},{"key":"i1543-2165-127-11-1458-b2","series-title":"Cancer","first-page":"2503","article-title":"Medullary breast carcinoma: a reevaluation of 95 cases of breast cancer with inflammatory stroma.","volume":"61","author":"Rapin, V.","year":"1988","unstructured":"Rapin, V., G.Contesso, and H.Mouriesse. et al. Medullary breast carcinoma: a reevaluation of 95 cases of breast cancer with inflammatory stroma.Cancer1988. 61:2503\u20132510."},{"key":"i1543-2165-127-11-1458-b3","series-title":"Hum Pathol","first-page":"1340","article-title":"Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria.","volume":"19","author":"Wargotz, E. S.","year":"1988","unstructured":"Wargotz, E. S. and S. G.Silverberg. Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria.Hum Pathol1988. 19:1340\u20131346."},{"key":"i1543-2165-127-11-1458-b4","series-title":"Histopathology","first-page":"523","article-title":"Prognostic comparison of three classifications for medullary carcinomas of the breast.","volume":"30","author":"Jensen, M. L.","year":"1997","unstructured":"Jensen, M. L., H.Kiaer, J.Andersen, J.Jensen, and F.Melsen. Prognostic comparison of three classifications for medullary carcinomas of the breast.Histopathology1997. 30:523\u2013532."},{"key":"i1543-2165-127-11-1458-b5","series-title":"Mod Pathol","first-page":"31","article-title":"Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis.","volume":"8","author":"Gaffey, M. J.","year":"1995","unstructured":"Gaffey, M. J., S. E.Mills, and H. F. JrFrierson. et al. Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis.Mod Pathol1995. 8:31\u201338."},{"key":"i1543-2165-127-11-1458-b6","series-title":"Arch Pathol Lab Med","first-page":"1005","article-title":"Medullary carcinoma of the breast: a multicenter study of its diagnostic consistency.","volume":"117","author":"Rigaud, C.","year":"1993","unstructured":"Rigaud, C., S.Theobald, and P.Noel. et al. Medullary carcinoma of the breast: a multicenter study of its diagnostic consistency.Arch Pathol Lab Med1993. 117:1005\u20131008."},{"key":"i1543-2165-127-11-1458-b7","series-title":"Arch Surg","first-page":"601","article-title":"Medullary carcinoma of the breast: overdiagnosis of a prognostically favorable neoplasm.","volume":"125","author":"Rubens, J. R.","year":"1990","unstructured":"Rubens, J. R., K. B.Lewandroski, D. B.Kopans, F. C.Koerner, D. A.Hall, and K. A.McCarthy. Medullary carcinoma of the breast: overdiagnosis of a prognostically favorable neoplasm.Arch Surg1990. 125:601\u2013604."},{"key":"i1543-2165-127-11-1458-b8","series-title":"Radiology","first-page":"443","article-title":"Overdiagnosis of medullary carcinoma: a mammographic-pathologic correlative study.","volume":"201","author":"Liberman, L.","year":"1996","unstructured":"Liberman, L., L. R.LaTrenta, B.Samli, E. A.Morris, A. F.Abramson, and D. D.Dershaw. Overdiagnosis of medullary carcinoma: a mammographic-pathologic correlative study.Radiology1996. 201:443\u2013446."},{"key":"i1543-2165-127-11-1458-b9","series-title":"J Clin Ultrasound","first-page":"325","article-title":"Sonographic and pathologic findings in typical and atypical medullary carcinomas of the breast.","volume":"28","author":"Cheung, Y. C.","year":"2000","unstructured":"Cheung, Y. C., S. C.Chen, K. F.Lee, Y. L.Wan, and S. H.Ng. Sonographic and pathologic findings in typical and atypical medullary carcinomas of the breast.J Clin Ultrasound2000. 28:325\u2013331."},{"key":"i1543-2165-127-11-1458-b10","series-title":"Ultrastruct Pathol","first-page":"499","article-title":"Medullary carcinoma of the breast: an ultrastructural morphometric study of nine cases.","volume":"21","author":"Lloreta, J.","year":"1997","unstructured":"Lloreta, J., M. L.Marinoso, J. M.Corominas, M. A.Canas, and S.Serrano. Medullary carcinoma of the breast: an ultrastructural morphometric study of nine cases.Ultrastruct Pathol1997. 21:499\u2013507."},{"key":"i1543-2165-127-11-1458-b11","series-title":"Histopathology","first-page":"405","article-title":"The ultrastructure of medullary, atypical medullary and non-medullary carcinomas of the breast.","volume":"10","author":"Harris, M.","year":"1986","unstructured":"Harris, M. and A. M.Lessells. The ultrastructure of medullary, atypical medullary and non-medullary carcinomas of the breast.Histopathology1986. 10:405\u2013414."},{"key":"i1543-2165-127-11-1458-b12","series-title":"Histopathology","first-page":"175","article-title":"The cytokeratin profile of medullary carcinoma of the breast.","volume":"37","author":"Tot, T.","year":"2000","unstructured":"Tot, T.\n          \n          The cytokeratin profile of medullary carcinoma of the breast.\n          Histopathology\n          2000. 37:175\u2013181."},{"key":"i1543-2165-127-11-1458-b13","series-title":"Med Pregl","first-page":"227","article-title":"Cytokeratins 7 and 14 in special types of invasive breast carcinomas.","volume":"52","author":"Toth, T.","year":"1999","unstructured":"Toth, T.\n          \n          Cytokeratins 7 and 14 in special types of invasive breast carcinomas.\n          Med Pregl\n          1999. 52:227\u2013232."},{"key":"i1543-2165-127-11-1458-b14","series-title":"Histopathology","first-page":"241","article-title":"Medullary breast carcinoma vs. poorly differentiated ductal carcinoma: an immunohistochemical study with keratin 19 and oestrogen receptor staining.","volume":"29","author":"Jensen, M. L.","year":"1996","unstructured":"Jensen, M. L., H.Kiaer, and F.Melsen. Medullary breast carcinoma vs. poorly differentiated ductal carcinoma: an immunohistochemical study with keratin 19 and oestrogen receptor staining.Histopathology1996. 29:241\u2013245."},{"key":"i1543-2165-127-11-1458-b15","series-title":"Mod Pathol","first-page":"413","article-title":"Keratin 19 in paraffin sections of medullary carcinoma and other benign and malignant breast lesions.","volume":"8","author":"Dalal, P.","year":"1995","unstructured":"Dalal, P. and S.Shousha. Keratin 19 in paraffin sections of medullary carcinoma and other benign and malignant breast lesions.Mod Pathol1995. 8:413\u2013416."},{"key":"i1543-2165-127-11-1458-b16","series-title":"J Natl Cancer Inst","first-page":"641","article-title":"Liva S, et al. p53 mutation as a genetic trait of typical medullary breast carcinoma.","volume":"91","author":"de Cremoux, P.","year":"1999","unstructured":"de Cremoux, P. and A. V.Salomon. Liva S, et al. p53 mutation as a genetic trait of typical medullary breast carcinoma.J Natl Cancer Inst1999. 91:641\u2013643."},{"key":"i1543-2165-127-11-1458-b17","series-title":"J Clin Oncol","first-page":"821","article-title":"Norton L. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.","volume":"13","author":"Rosen, P. P.","year":"1995","unstructured":"Rosen, P. P., M. L.Lesser, C. D.Arroyo, M.Cranor, and P.Borgen. Norton L. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.J Clin Oncol1995. 13:821\u2013830."},{"key":"i1543-2165-127-11-1458-b18","series-title":"Virchows Arch","first-page":"125","article-title":"MIB-1 expression in breast carcinomas with medullary features: an immunohistological study including correlations with p53 and bcl-2.","volume":"431","author":"Jensen, V.","year":"1997","unstructured":"Jensen, V., M. L.Jensen, H.Kiaer, J.Andersen, and F.Melsen. MIB-1 expression in breast carcinomas with medullary features: an immunohistological study including correlations with p53 and bcl-2.Virchows Arch1997. 431:125\u2013130."},{"key":"i1543-2165-127-11-1458-b19","series-title":"J Clin Pathol","first-page":"926","article-title":"MIB-1 proliferative activity in invasive breast cancer measured by image analysis.","volume":"49","author":"Querzoli, P.","year":"1996","unstructured":"Querzoli, P., G.Albonico, and S.Ferretti. et al. MIB-1 proliferative activity in invasive breast cancer measured by image analysis.J Clin Pathol1996. 49:926\u2013930."},{"key":"i1543-2165-127-11-1458-b20","series-title":"Cancer Lett","first-page":"207","article-title":"Clinical value of the wild-type estrogen receptor beta expression in breast cancer.","volume":"163","author":"Omoto, Y.","year":"2001","unstructured":"Omoto, Y., S.Inoue, and S.Ogawa. et al. Clinical value of the wild-type estrogen receptor beta expression in breast cancer.Cancer Lett2001. 163:207\u2013212."},{"key":"i1543-2165-127-11-1458-b21","series-title":"J Clin Pathol","first-page":"1009","article-title":"Epidermal growth factor receptor immunohistochemistry in different histological types of infiltrating breast carcinoma.","volume":"46","author":"Martinazzi, M.","year":"1993","unstructured":"Martinazzi, M., F.Crivelli, C.Zampatti, and S.Martinazzi. Epidermal growth factor receptor immunohistochemistry in different histological types of infiltrating breast carcinoma.J Clin Pathol1993. 46:1009\u20131010."},{"key":"i1543-2165-127-11-1458-b22","series-title":"Cancer","first-page":"1320","article-title":"Immunohistochemical detection of HER2\/neu in patients with axillary lymph node negative breast carcinoma: a study of epidemiologic risk factors, histologic features, and prognosis.","volume":"75","author":"Rosen, P. P.","year":"1995","unstructured":"Rosen, P. P., M. L.Lesser, C. D.Arroyo, M.Cranor, P.Borgen, and L.Norton. Immunohistochemical detection of HER2\/neu in patients with axillary lymph node negative breast carcinoma: a study of epidemiologic risk factors, histologic features, and prognosis.Cancer1995. 75:1320\u20131326."},{"key":"i1543-2165-127-11-1458-b23","series-title":"Cancer Res","first-page":"6941","article-title":"c-erbB-2 amplification in node-negative human breast cancer.","volume":"49","author":"Ro, J. S.","year":"1989","unstructured":"Ro, J. S., A.el-Naggar, and J. Y.Ro. et al. c-erbB-2 amplification in node-negative human breast cancer.Cancer Res1989. 49:(24 pt 1). 6941\u20136944."},{"key":"i1543-2165-127-11-1458-b24","series-title":"J Cancer Res Clin Oncol","first-page":"15","article-title":"Reiche C, et al. c-erbB2 expression in correlation to other biological parameters of breast cancer.","volume":"116","author":"Marx, D.","year":"1990","unstructured":"Marx, D. and A.Schauer. Reiche C, et al. c-erbB2 expression in correlation to other biological parameters of breast cancer.J Cancer Res Clin Oncol1990. 116:15\u201320."},{"key":"i1543-2165-127-11-1458-b25","series-title":"Cancer","first-page":"1794","article-title":"Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast carcinoma: a retrospective analysis of 176 cases.","volume":"65","author":"Tsuda, H.","year":"1990","unstructured":"Tsuda, H., S.Hirohashi, and Y.Shimosato. et al. Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast carcinoma: a retrospective analysis of 176 cases.Cancer1990. 65:1794\u20131800."},{"key":"i1543-2165-127-11-1458-b26","series-title":"N Engl J Med","first-page":"1239","article-title":"Neu-protein overexpression in breast cancer: association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.","volume":"319","author":"van de Vijver, M. J.","year":"1988","unstructured":"van de Vijver, M. J., J. L.Peterse, and W. J.Mooi. et al. Neu-protein overexpression in breast cancer: association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.N Engl J Med1988. 319:1239\u20131245."},{"key":"i1543-2165-127-11-1458-b27","series-title":"Am J Pathol","first-page":"1337","article-title":"Medullary carcinoma is associated with expression of intercellular adhesion molecule-1: implication to its morphology and its clinical behavior.","volume":"145","author":"Bacus, S. S.","year":"1994","unstructured":"Bacus, S. S., C. R.Zelnick, and D. M.Chin. et al. Medullary carcinoma is associated with expression of intercellular adhesion molecule-1: implication to its morphology and its clinical behavior.Am J Pathol1994. 145:1337\u20131348."},{"key":"i1543-2165-127-11-1458-b28","series-title":"Mod Pathol","first-page":"116","article-title":"Amplification of Her-2\/neu gene in Her-2\/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.","volume":"15","author":"Xu, R.","year":"2002","unstructured":"Xu, R., M. A.Perle, G.Inghirami, W.Chan, Y.Delgado, and H.Feiner. Amplification of Her-2\/neu gene in Her-2\/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.Mod Pathol2002. 15:116\u2013124."},{"key":"i1543-2165-127-11-1458-b29","series-title":"Am J Clin Pathol","first-page":"17","article-title":"Comparison of DNA content, S-phase fraction, and survival between medullary and ductal carcinoma of the breast.","volume":"104","author":"Cook, D. L.","year":"1995","unstructured":"Cook, D. L. and D. L.Weaver. Comparison of DNA content, S-phase fraction, and survival between medullary and ductal carcinoma of the breast.Am J Clin Pathol1995. 104:17\u201322."},{"key":"i1543-2165-127-11-1458-b30","series-title":"J Surg Oncol Suppl","first-page":"209","article-title":"Apoptosis and cell proliferation in medullary carcinoma of the breast: a comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry.","volume":"70","author":"Kajiwara, M.","year":"1999","unstructured":"Kajiwara, M., S.Toyoshima, T.Yao, M.Tanaka, and M.Tsuneyoshi. Apoptosis and cell proliferation in medullary carcinoma of the breast: a comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry.J Surg Oncol Suppl1999. 70:209\u2013216."},{"key":"i1543-2165-127-11-1458-b31","series-title":"J Clin Pathol","first-page":"286","article-title":"HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.","volume":"53","author":"Feinmesser, M.","year":"2000","unstructured":"Feinmesser, M., A.Sulkes, S.Morgenstern, J.Sulkes, S.Stern, and E.Okon. HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.J Clin Pathol2000. 53:286\u2013291."},{"key":"i1543-2165-127-11-1458-b32","series-title":"Int J Oncol","first-page":"285","article-title":"E-cadherin and beta-catenin expression in breast medullary carcinomas.","volume":"15","author":"Charpin, C.","year":"1999","unstructured":"Charpin, C., P.Bonnier, and S.Garcia. et al. E-cadherin and beta-catenin expression in breast medullary carcinomas.Int J Oncol1999. 15:285\u2013292."},{"key":"i1543-2165-127-11-1458-b33","series-title":"Oncogene","first-page":"5810","article-title":"WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type.","volume":"20","author":"Ugolini, F.","year":"2001","unstructured":"Ugolini, F., E.Charafe-Jauffret, and V. J.Bardou. et al. WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type.Oncogene2001. 20:5810\u20135817."},{"key":"i1543-2165-127-11-1458-b34","series-title":"Am J Clin Pathol","first-page":"823","article-title":"Microsatellite instability is infrequent in medullary breast cancer.","volume":"115","author":"Lee, S. C.","year":"2001","unstructured":"Lee, S. C., K. D.Berg, M. E.Sherman, C. A.Griffin, and J. R.Eshleman. Microsatellite instability is infrequent in medullary breast cancer.Am J Clin Pathol2001. 115:823\u2013827."},{"key":"i1543-2165-127-11-1458-b35","series-title":"Cancer Res","first-page":"7889","article-title":"Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer.","volume":"61","author":"Coronella, J. A.","year":"2001","unstructured":"Coronella, J. A., P.Telleman, G. A.Kingsbury, T. D.Truong, S.Hays, and R. P.Junghans. Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer.Cancer Res2001. 61:7889\u20137899."},{"key":"i1543-2165-127-11-1458-b36","series-title":"Proc Natl Acad Sci U S A","first-page":"12659","article-title":"The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells.","volume":"98","author":"Hansen, M. H.","year":"2001","unstructured":"Hansen, M. H., H.Nielsen, and H. J.Ditzel. The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells.Proc Natl Acad Sci U S A2001. 98:12659\u201312664."},{"key":"i1543-2165-127-11-1458-b37","series-title":"Mod Pathol","first-page":"1050","article-title":"Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast.","volume":"12","author":"Yakirevich, E.","year":"1999","unstructured":"Yakirevich, E., O. B.Izhak, G.Rennert, Z. G.Kovacs, and M. B.Resnick. Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast.Mod Pathol1999. 12:1050\u20131056."},{"key":"i1543-2165-127-11-1458-b38","series-title":"Mod Pathol","first-page":"721","article-title":"Medullary carcinoma of the breast: identification of lymphocyte subpopulations and their significance.","volume":"6","author":"Gaffey, M. J.","year":"1993","unstructured":"Gaffey, M. J., H. F. JrFrierson, and S. E.Mills. et al. Medullary carcinoma of the breast: identification of lymphocyte subpopulations and their significance.Mod Pathol1993. 6:721\u2013728."},{"key":"i1543-2165-127-11-1458-b39","series-title":"Am J Clin Pathol","first-page":"449","article-title":"Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction.","volume":"103","author":"Lespagnard, L.","year":"1995","unstructured":"Lespagnard, L., P.Cochaux, D.Larsimont, M.Degeyter, T.Velu, and R.Heimann. Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction.Am J Clin Pathol1995. 103:449\u2013452."},{"key":"i1543-2165-127-11-1458-b40","series-title":"Oncology","first-page":"1","article-title":"Biology of HER2 and its importance in breast cancer [review].","volume":"61","author":"Yarden, Y.","year":"2001","unstructured":"Yarden, Y.\n          \n          Biology of HER2 and its importance in breast cancer [review].\n          Oncology\n          2001. 61:(suppl 2). 1\u201313."},{"key":"i1543-2165-127-11-1458-b41","series-title":"Mod Pathol","first-page":"213","article-title":"Breast cancer in the 21st century: neu opportunities and neu challenges [review].","volume":"14","author":"Schnitt, S. J.","year":"2001","unstructured":"Schnitt, S. J.\n          \n          Breast cancer in the 21st century: neu opportunities and neu challenges [review].\n          Mod Pathol\n          2001. 14:213\u2013218."},{"key":"i1543-2165-127-11-1458-b42","series-title":"Anticancer Res","first-page":"65","article-title":"Immunohistochemical analysis of p53 expression in primary breast carcinomas.","volume":"18","author":"Naidu, R.","year":"1998","unstructured":"Naidu, R., M.Yadav, S.Nair, and K. K.Kutty. Immunohistochemical analysis of p53 expression in primary breast carcinomas.Anticancer Res1998. 18:65\u201370."},{"key":"i1543-2165-127-11-1458-b43","series-title":"Pathologica","first-page":"33","article-title":"Low, intermediate and high grade breast carcinomas as determined by histotyping, immunohistochemical prognosticators and histological grading.","volume":"84","author":"Martinazzi, M.","year":"1992","unstructured":"Martinazzi, M., F.Crivelli, C.Zampatti, and P.Pisani. Low, intermediate and high grade breast carcinomas as determined by histotyping, immunohistochemical prognosticators and histological grading.Pathologica1992. 84:33\u201347."},{"key":"i1543-2165-127-11-1458-b44","series-title":"Nature","first-page":"530","article-title":"Gene expression profiling predicts clinical outcome of breast cancer.","volume":"415","author":"van 't Veer, L. J.","year":"2002","unstructured":"van 't Veer, L. J., H.Dai, and M. J.van de Vijver. et al. Gene expression profiling predicts clinical outcome of breast cancer.Nature2002. 415:530\u2013536."},{"key":"i1543-2165-127-11-1458-b1","series-title":"Cancer","first-page":"1365","article-title":"Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up.","volume":"40","author":"Ridolfi, R. L.","year":"1977","unstructured":"Ridolfi, R. L., P. P.Rosen, A.Port, D.Kinne, and V.Mike. Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up.Cancer1977. 40:1365\u20131385."},{"key":"i1543-2165-127-11-1458-b2","series-title":"Cancer","first-page":"2503","article-title":"Medullary breast carcinoma: a reevaluation of 95 cases of breast cancer with inflammatory stroma.","volume":"61","author":"Rapin, V.","year":"1988","unstructured":"Rapin, V., G.Contesso, and H.Mouriesse. et al. Medullary breast carcinoma: a reevaluation of 95 cases of breast cancer with inflammatory stroma.Cancer1988. 61:2503\u20132510."},{"key":"i1543-2165-127-11-1458-b3","series-title":"Hum Pathol","first-page":"1340","article-title":"Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria.","volume":"19","author":"Wargotz, E. S.","year":"1988","unstructured":"Wargotz, E. S. and S. G.Silverberg. Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria.Hum Pathol1988. 19:1340\u20131346."},{"key":"i1543-2165-127-11-1458-b4","series-title":"Histopathology","first-page":"523","article-title":"Prognostic comparison of three classifications for medullary carcinomas of the breast.","volume":"30","author":"Jensen, M. L.","year":"1997","unstructured":"Jensen, M. L., H.Kiaer, J.Andersen, J.Jensen, and F.Melsen. Prognostic comparison of three classifications for medullary carcinomas of the breast.Histopathology1997. 30:523\u2013532."},{"key":"i1543-2165-127-11-1458-b5","series-title":"Mod Pathol","first-page":"31","article-title":"Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis.","volume":"8","author":"Gaffey, M. J.","year":"1995","unstructured":"Gaffey, M. J., S. E.Mills, and H. F. JrFrierson. et al. Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis.Mod Pathol1995. 8:31\u201338."},{"key":"i1543-2165-127-11-1458-b6","series-title":"Arch Pathol Lab Med","first-page":"1005","article-title":"Medullary carcinoma of the breast: a multicenter study of its diagnostic consistency.","volume":"117","author":"Rigaud, C.","year":"1993","unstructured":"Rigaud, C., S.Theobald, and P.Noel. et al. Medullary carcinoma of the breast: a multicenter study of its diagnostic consistency.Arch Pathol Lab Med1993. 117:1005\u20131008."},{"key":"i1543-2165-127-11-1458-b7","series-title":"Arch Surg","first-page":"601","article-title":"Medullary carcinoma of the breast: overdiagnosis of a prognostically favorable neoplasm.","volume":"125","author":"Rubens, J. R.","year":"1990","unstructured":"Rubens, J. R., K. B.Lewandroski, D. B.Kopans, F. C.Koerner, D. A.Hall, and K. A.McCarthy. Medullary carcinoma of the breast: overdiagnosis of a prognostically favorable neoplasm.Arch Surg1990. 125:601\u2013604."},{"key":"i1543-2165-127-11-1458-b8","series-title":"Radiology","first-page":"443","article-title":"Overdiagnosis of medullary carcinoma: a mammographic-pathologic correlative study.","volume":"201","author":"Liberman, L.","year":"1996","unstructured":"Liberman, L., L. R.LaTrenta, B.Samli, E. A.Morris, A. F.Abramson, and D. D.Dershaw. Overdiagnosis of medullary carcinoma: a mammographic-pathologic correlative study.Radiology1996. 201:443\u2013446."},{"key":"i1543-2165-127-11-1458-b9","series-title":"J Clin Ultrasound","first-page":"325","article-title":"Sonographic and pathologic findings in typical and atypical medullary carcinomas of the breast.","volume":"28","author":"Cheung, Y. C.","year":"2000","unstructured":"Cheung, Y. C., S. C.Chen, K. F.Lee, Y. L.Wan, and S. H.Ng. Sonographic and pathologic findings in typical and atypical medullary carcinomas of the breast.J Clin Ultrasound2000. 28:325\u2013331."},{"key":"i1543-2165-127-11-1458-b10","series-title":"Ultrastruct Pathol","first-page":"499","article-title":"Medullary carcinoma of the breast: an ultrastructural morphometric study of nine cases.","volume":"21","author":"Lloreta, J.","year":"1997","unstructured":"Lloreta, J., M. L.Marinoso, J. M.Corominas, M. A.Canas, and S.Serrano. Medullary carcinoma of the breast: an ultrastructural morphometric study of nine cases.Ultrastruct Pathol1997. 21:499\u2013507."},{"key":"i1543-2165-127-11-1458-b11","series-title":"Histopathology","first-page":"405","article-title":"The ultrastructure of medullary, atypical medullary and non-medullary carcinomas of the breast.","volume":"10","author":"Harris, M.","year":"1986","unstructured":"Harris, M. and A. M.Lessells. The ultrastructure of medullary, atypical medullary and non-medullary carcinomas of the breast.Histopathology1986. 10:405\u2013414."},{"key":"i1543-2165-127-11-1458-b12","series-title":"Histopathology","first-page":"175","article-title":"The cytokeratin profile of medullary carcinoma of the breast.","volume":"37","author":"Tot, T.","year":"2000","unstructured":"Tot, T.\n          \n          The cytokeratin profile of medullary carcinoma of the breast.\n          Histopathology\n          2000. 37:175\u2013181."},{"key":"i1543-2165-127-11-1458-b13","series-title":"Med Pregl","first-page":"227","article-title":"Cytokeratins 7 and 14 in special types of invasive breast carcinomas.","volume":"52","author":"Toth, T.","year":"1999","unstructured":"Toth, T.\n          \n          Cytokeratins 7 and 14 in special types of invasive breast carcinomas.\n          Med Pregl\n          1999. 52:227\u2013232."},{"key":"i1543-2165-127-11-1458-b14","series-title":"Histopathology","first-page":"241","article-title":"Medullary breast carcinoma vs. poorly differentiated ductal carcinoma: an immunohistochemical study with keratin 19 and oestrogen receptor staining.","volume":"29","author":"Jensen, M. L.","year":"1996","unstructured":"Jensen, M. L., H.Kiaer, and F.Melsen. Medullary breast carcinoma vs. poorly differentiated ductal carcinoma: an immunohistochemical study with keratin 19 and oestrogen receptor staining.Histopathology1996. 29:241\u2013245."},{"key":"i1543-2165-127-11-1458-b15","series-title":"Mod Pathol","first-page":"413","article-title":"Keratin 19 in paraffin sections of medullary carcinoma and other benign and malignant breast lesions.","volume":"8","author":"Dalal, P.","year":"1995","unstructured":"Dalal, P. and S.Shousha. Keratin 19 in paraffin sections of medullary carcinoma and other benign and malignant breast lesions.Mod Pathol1995. 8:413\u2013416."},{"key":"i1543-2165-127-11-1458-b16","series-title":"J Natl Cancer Inst","first-page":"641","article-title":"Liva S, et al. p53 mutation as a genetic trait of typical medullary breast carcinoma.","volume":"91","author":"de Cremoux, P.","year":"1999","unstructured":"de Cremoux, P. and A. V.Salomon. Liva S, et al. p53 mutation as a genetic trait of typical medullary breast carcinoma.J Natl Cancer Inst1999. 91:641\u2013643."},{"key":"i1543-2165-127-11-1458-b17","series-title":"J Clin Oncol","first-page":"821","article-title":"Norton L. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.","volume":"13","author":"Rosen, P. P.","year":"1995","unstructured":"Rosen, P. P., M. L.Lesser, C. D.Arroyo, M.Cranor, and P.Borgen. Norton L. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.J Clin Oncol1995. 13:821\u2013830."},{"key":"i1543-2165-127-11-1458-b18","series-title":"Virchows Arch","first-page":"125","article-title":"MIB-1 expression in breast carcinomas with medullary features: an immunohistological study including correlations with p53 and bcl-2.","volume":"431","author":"Jensen, V.","year":"1997","unstructured":"Jensen, V., M. L.Jensen, H.Kiaer, J.Andersen, and F.Melsen. MIB-1 expression in breast carcinomas with medullary features: an immunohistological study including correlations with p53 and bcl-2.Virchows Arch1997. 431:125\u2013130."},{"key":"i1543-2165-127-11-1458-b19","series-title":"J Clin Pathol","first-page":"926","article-title":"MIB-1 proliferative activity in invasive breast cancer measured by image analysis.","volume":"49","author":"Querzoli, P.","year":"1996","unstructured":"Querzoli, P., G.Albonico, and S.Ferretti. et al. MIB-1 proliferative activity in invasive breast cancer measured by image analysis.J Clin Pathol1996. 49:926\u2013930."},{"key":"i1543-2165-127-11-1458-b20","series-title":"Cancer Lett","first-page":"207","article-title":"Clinical value of the wild-type estrogen receptor beta expression in breast cancer.","volume":"163","author":"Omoto, Y.","year":"2001","unstructured":"Omoto, Y., S.Inoue, and S.Ogawa. et al. Clinical value of the wild-type estrogen receptor beta expression in breast cancer.Cancer Lett2001. 163:207\u2013212."},{"key":"i1543-2165-127-11-1458-b21","series-title":"J Clin Pathol","first-page":"1009","article-title":"Epidermal growth factor receptor immunohistochemistry in different histological types of infiltrating breast carcinoma.","volume":"46","author":"Martinazzi, M.","year":"1993","unstructured":"Martinazzi, M., F.Crivelli, C.Zampatti, and S.Martinazzi. Epidermal growth factor receptor immunohistochemistry in different histological types of infiltrating breast carcinoma.J Clin Pathol1993. 46:1009\u20131010."},{"key":"i1543-2165-127-11-1458-b22","series-title":"Cancer","first-page":"1320","article-title":"Immunohistochemical detection of HER2\/neu in patients with axillary lymph node negative breast carcinoma: a study of epidemiologic risk factors, histologic features, and prognosis.","volume":"75","author":"Rosen, P. P.","year":"1995","unstructured":"Rosen, P. P., M. L.Lesser, C. D.Arroyo, M.Cranor, P.Borgen, and L.Norton. Immunohistochemical detection of HER2\/neu in patients with axillary lymph node negative breast carcinoma: a study of epidemiologic risk factors, histologic features, and prognosis.Cancer1995. 75:1320\u20131326."},{"key":"i1543-2165-127-11-1458-b23","series-title":"Cancer Res","first-page":"6941","article-title":"c-erbB-2 amplification in node-negative human breast cancer.","volume":"49","author":"Ro, J. S.","year":"1989","unstructured":"Ro, J. S., A.el-Naggar, and J. Y.Ro. et al. c-erbB-2 amplification in node-negative human breast cancer.Cancer Res1989. 49:(24 pt 1). 6941\u20136944."},{"key":"i1543-2165-127-11-1458-b24","series-title":"J Cancer Res Clin Oncol","first-page":"15","article-title":"Reiche C, et al. c-erbB2 expression in correlation to other biological parameters of breast cancer.","volume":"116","author":"Marx, D.","year":"1990","unstructured":"Marx, D. and A.Schauer. Reiche C, et al. c-erbB2 expression in correlation to other biological parameters of breast cancer.J Cancer Res Clin Oncol1990. 116:15\u201320."},{"key":"i1543-2165-127-11-1458-b25","series-title":"Cancer","first-page":"1794","article-title":"Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast carcinoma: a retrospective analysis of 176 cases.","volume":"65","author":"Tsuda, H.","year":"1990","unstructured":"Tsuda, H., S.Hirohashi, and Y.Shimosato. et al. Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast carcinoma: a retrospective analysis of 176 cases.Cancer1990. 65:1794\u20131800."},{"key":"i1543-2165-127-11-1458-b26","series-title":"N Engl J Med","first-page":"1239","article-title":"Neu-protein overexpression in breast cancer: association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.","volume":"319","author":"van de Vijver, M. J.","year":"1988","unstructured":"van de Vijver, M. J., J. L.Peterse, and W. J.Mooi. et al. Neu-protein overexpression in breast cancer: association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.N Engl J Med1988. 319:1239\u20131245."},{"key":"i1543-2165-127-11-1458-b27","series-title":"Am J Pathol","first-page":"1337","article-title":"Medullary carcinoma is associated with expression of intercellular adhesion molecule-1: implication to its morphology and its clinical behavior.","volume":"145","author":"Bacus, S. S.","year":"1994","unstructured":"Bacus, S. S., C. R.Zelnick, and D. M.Chin. et al. Medullary carcinoma is associated with expression of intercellular adhesion molecule-1: implication to its morphology and its clinical behavior.Am J Pathol1994. 145:1337\u20131348."},{"key":"i1543-2165-127-11-1458-b28","series-title":"Mod Pathol","first-page":"116","article-title":"Amplification of Her-2\/neu gene in Her-2\/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.","volume":"15","author":"Xu, R.","year":"2002","unstructured":"Xu, R., M. A.Perle, G.Inghirami, W.Chan, Y.Delgado, and H.Feiner. Amplification of Her-2\/neu gene in Her-2\/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.Mod Pathol2002. 15:116\u2013124."},{"key":"i1543-2165-127-11-1458-b29","series-title":"Am J Clin Pathol","first-page":"17","article-title":"Comparison of DNA content, S-phase fraction, and survival between medullary and ductal carcinoma of the breast.","volume":"104","author":"Cook, D. L.","year":"1995","unstructured":"Cook, D. L. and D. L.Weaver. Comparison of DNA content, S-phase fraction, and survival between medullary and ductal carcinoma of the breast.Am J Clin Pathol1995. 104:17\u201322."},{"key":"i1543-2165-127-11-1458-b30","series-title":"J Surg Oncol Suppl","first-page":"209","article-title":"Apoptosis and cell proliferation in medullary carcinoma of the breast: a comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry.","volume":"70","author":"Kajiwara, M.","year":"1999","unstructured":"Kajiwara, M., S.Toyoshima, T.Yao, M.Tanaka, and M.Tsuneyoshi. Apoptosis and cell proliferation in medullary carcinoma of the breast: a comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry.J Surg Oncol Suppl1999. 70:209\u2013216."},{"key":"i1543-2165-127-11-1458-b31","series-title":"J Clin Pathol","first-page":"286","article-title":"HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.","volume":"53","author":"Feinmesser, M.","year":"2000","unstructured":"Feinmesser, M., A.Sulkes, S.Morgenstern, J.Sulkes, S.Stern, and E.Okon. HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.J Clin Pathol2000. 53:286\u2013291."},{"key":"i1543-2165-127-11-1458-b32","series-title":"Int J Oncol","first-page":"285","article-title":"E-cadherin and beta-catenin expression in breast medullary carcinomas.","volume":"15","author":"Charpin, C.","year":"1999","unstructured":"Charpin, C., P.Bonnier, and S.Garcia. et al. E-cadherin and beta-catenin expression in breast medullary carcinomas.Int J Oncol1999. 15:285\u2013292."},{"key":"i1543-2165-127-11-1458-b33","series-title":"Oncogene","first-page":"5810","article-title":"WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type.","volume":"20","author":"Ugolini, F.","year":"2001","unstructured":"Ugolini, F., E.Charafe-Jauffret, and V. J.Bardou. et al. WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type.Oncogene2001. 20:5810\u20135817."},{"key":"i1543-2165-127-11-1458-b34","series-title":"Am J Clin Pathol","first-page":"823","article-title":"Microsatellite instability is infrequent in medullary breast cancer.","volume":"115","author":"Lee, S. C.","year":"2001","unstructured":"Lee, S. C., K. D.Berg, M. E.Sherman, C. A.Griffin, and J. R.Eshleman. Microsatellite instability is infrequent in medullary breast cancer.Am J Clin Pathol2001. 115:823\u2013827."},{"key":"i1543-2165-127-11-1458-b35","series-title":"Cancer Res","first-page":"7889","article-title":"Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer.","volume":"61","author":"Coronella, J. A.","year":"2001","unstructured":"Coronella, J. A., P.Telleman, G. A.Kingsbury, T. D.Truong, S.Hays, and R. P.Junghans. Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer.Cancer Res2001. 61:7889\u20137899."},{"key":"i1543-2165-127-11-1458-b36","series-title":"Proc Natl Acad Sci U S A","first-page":"12659","article-title":"The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells.","volume":"98","author":"Hansen, M. H.","year":"2001","unstructured":"Hansen, M. H., H.Nielsen, and H. J.Ditzel. The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells.Proc Natl Acad Sci U S A2001. 98:12659\u201312664."},{"key":"i1543-2165-127-11-1458-b37","series-title":"Mod Pathol","first-page":"1050","article-title":"Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast.","volume":"12","author":"Yakirevich, E.","year":"1999","unstructured":"Yakirevich, E., O. B.Izhak, G.Rennert, Z. G.Kovacs, and M. B.Resnick. Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast.Mod Pathol1999. 12:1050\u20131056."},{"key":"i1543-2165-127-11-1458-b38","series-title":"Mod Pathol","first-page":"721","article-title":"Medullary carcinoma of the breast: identification of lymphocyte subpopulations and their significance.","volume":"6","author":"Gaffey, M. J.","year":"1993","unstructured":"Gaffey, M. J., H. F. JrFrierson, and S. E.Mills. et al. Medullary carcinoma of the breast: identification of lymphocyte subpopulations and their significance.Mod Pathol1993. 6:721\u2013728."},{"key":"i1543-2165-127-11-1458-b39","series-title":"Am J Clin Pathol","first-page":"449","article-title":"Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction.","volume":"103","author":"Lespagnard, L.","year":"1995","unstructured":"Lespagnard, L., P.Cochaux, D.Larsimont, M.Degeyter, T.Velu, and R.Heimann. Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction.Am J Clin Pathol1995. 103:449\u2013452."},{"key":"i1543-2165-127-11-1458-b40","series-title":"Oncology","first-page":"1","article-title":"Biology of HER2 and its importance in breast cancer [review].","volume":"61","author":"Yarden, Y.","year":"2001","unstructured":"Yarden, Y.\n          \n          Biology of HER2 and its importance in breast cancer [review].\n          Oncology\n          2001. 61:(suppl 2). 1\u201313."},{"key":"i1543-2165-127-11-1458-b41","series-title":"Mod Pathol","first-page":"213","article-title":"Breast cancer in the 21st century: neu opportunities and neu challenges [review].","volume":"14","author":"Schnitt, S. J.","year":"2001","unstructured":"Schnitt, S. J.\n          \n          Breast cancer in the 21st century: neu opportunities and neu challenges [review].\n          Mod Pathol\n          2001. 14:213\u2013218."},{"key":"i1543-2165-127-11-1458-b42","series-title":"Anticancer Res","first-page":"65","article-title":"Immunohistochemical analysis of p53 expression in primary breast carcinomas.","volume":"18","author":"Naidu, R.","year":"1998","unstructured":"Naidu, R., M.Yadav, S.Nair, and K. K.Kutty. Immunohistochemical analysis of p53 expression in primary breast carcinomas.Anticancer Res1998. 18:65\u201370."},{"key":"i1543-2165-127-11-1458-b43","series-title":"Pathologica","first-page":"33","article-title":"Low, intermediate and high grade breast carcinomas as determined by histotyping, immunohistochemical prognosticators and histological grading.","volume":"84","author":"Martinazzi, M.","year":"1992","unstructured":"Martinazzi, M., F.Crivelli, C.Zampatti, and P.Pisani. Low, intermediate and high grade breast carcinomas as determined by histotyping, immunohistochemical prognosticators and histological grading.Pathologica1992. 84:33\u201347."},{"key":"i1543-2165-127-11-1458-b44","series-title":"Nature","first-page":"530","article-title":"Gene expression profiling predicts clinical outcome of breast cancer.","volume":"415","author":"van 't Veer, L. J.","year":"2002","unstructured":"van 't Veer, L. J., H.Dai, and M. J.van de Vijver. et al. Gene expression profiling predicts clinical outcome of breast cancer.Nature2002. 415:530\u2013536."}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/127\/11\/article-p1458.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/127\/11\/1458\/2752070\/1543-2165(2003)127_1458_daaoon_2_0_co_2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/127\/11\/article-p1458.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/127\/11\/article-p1458.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:06:23Z","timestamp":1770771983000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/127\/11\/article-p1458.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":88,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.5858\/2003-127-1458-daaoon","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}